EORTC protocol 11001

10B-uptake in different tumours using the boron compounds BSH and BPA.
Trial StatusOpen
DatesDate of activation: 29/04/2003
Data management at EORTCFull
Phase1
Randomized trialNo
Type-
Targeted Sample size27
Number of steps1
DrugPara-boronophenylalanine (BPA)
Sodium mercaptoundecahydro-closo-dodecaborate (BSH)
Study StaffWolfgang Sauerwein (Study Coordinator) - Universitaetsklinikum - Essen, Essen
Laurence Collette (Statistician) - EORTC, Brussels
Catherine Hermans (Data Manager) - EORTC, Brussels
Type of cancerLiver
Thyroid
Head and Neck
Participating GroupsEORTC Boron Neutron Capture Therapy Group (closed group)(Coordinating Group)
Currently authorized centers Universitaetsklinikum - Essen (Essen, Germany) - Inst. 509
Protocol summaryLink provided by NCI PDQ
Protocol documents in PDF (requires password)11001.pdf
Back to Protocol section